• Seer filed a complaint at the US International Trade Commission against Nanomics over alleged patent infringement tied to nanoparticle protein enrichment.
• The filing seeks an ITC investigation into imports of Nanomics’ Proteonano kits and workstations, aiming for an exclusion order blocking US entry.
• The ITC action follows a federal district court patent infringement suit filed May 12, 2026; Brigham and Women’s Hospital joined the ITC complaint.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Seer Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605290700PRIMZONEFULLFEED9728712) on May 29, 2026, and is solely responsible for the information contained therein.